0.028378 0.000000 0.000000 0.000000 0.028378 0.000000 0.000000 0.000000 0.009556 0.00000 0.00000 0.00000 Yadav, M.K. Leman, L.J. Stout, C.D. Ghadiri, M.R. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 16 90.00 90.00 90.00 35.238 35.238 104.647 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 45 4463 10.1021/BI060092Q 16584182 Coiled Coils at the Edge of Configurational Heterogeneity. Structural Analyses of Parallel and Antiparallel Homotetrameric Coiled Coils Reveal Configurational Sensitivity to a Single Solvent-Exposed Amino Acid Substitution. 2006 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 93.0 1 2004-06-26 NI FILTER SINGLE WAVELENGTH M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE RIGAKU RU200 PEPTIDE IS CAPPED WITH PARA ACETAMIDO BENZOIC ACID. 3995.802 GENERAL CONTROL PROTEIN GCN4 YES 2 syn polymer AMINO ACID BIOSYNTHESIS REGULATORY PROTEIN, PLI E20C Y17H no no RMKQIEDKLEEILSKLHHICNELARIKKLLGER RMKQIEDKLEEILSKLHHICNELARIKKLLGER A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n 1 2 38.9 VAPOR DIFFUSION, HANGING DROP 10.50 HANGING DROP, 1UL OF 1MG/ML PEPTIDE IN WATER, 1UL 100MM CAPS, 30% PEG 400, PH 10.5. database_PDB_rev database_PDB_rev_record exptl_crystal_grow pdbx_database_proc pdbx_database_status repository Initial release Version format compliance Version format compliance Data collection Experimental preparation Other 1 0 2004-09-24 1 1 2011-05-08 1 2 2011-07-13 1 3 2019-05-08 _exptl_crystal_grow.method _pdbx_database_status.recvd_author_approval HELIX CAPPING IN THE GCN4 LEUCINE ZIPPER GCN4 LEUCINE ZIPPER COMPLEXED WITH SPECIFIC ATF/CREB SITE DEOXYRIBONUCLEIC ACID ATOMIC STRUCTURE OF THE ECTODOMAIN FROM HIV -1 GP41 THE STRUCTURE OF AN HIV-1 SPECIFIC CELL ENTRY INHIBITOR INCOMPLEX WITH THE HIV-1 GP41 TRIMERIC CORE GCN4 LEUCINE ZIPPER CORE MUTANT P-LI GCN4 LEUCINE ZIPPER CORE MUTANT P-LI HUMAN VIMENTIN COIL 2B FRAGMENT LINKED TO GCN4 LEUCINE ZIPPER (Z2B) CRYSTAL STRUCTURE OF C14LINKMID/IQN17: A CROSS-LINKED INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 HYDROPHOBIC POCKET GLYTM1BZIP: A CHIMERIC PEPTIDE MODEL OF THE N-TERMINUS OF ARAT SHORT ALPHA TROPOMYOSIN WITH THE N-TERMINUS ENCODED BYEXON 1B COILED COIL TRIMER GCN4-PVLS SER AT BURIED D POSITION GCN4-PVLT COILED-COIL TRIMER WITH THREONINE AT THE D(12)POSITION GCN4-PVTL COILED-COIL TRIMER WITH THREONINE AT THE A(16)POSITION GCN4-PVSL COILED-COIL TRIMER WITH SERINE AT THE A(16)POSITION CRYSTAL STRUCTURE OF THE C-TERMINAL REGION OF STRIATEDMUSCLE ALPHA-TROPOMYOSIN AT 2.7 ANGSTROM RESOLUTION PLACEMENT OF THE STRUCTURAL PROTEINS IN SINDBIS VIRUS CRYSTAL STRUCTURE OF A ZIF23-GCN4 CHIMERA BOUND TO DNA VISUALIZING AN UNSTABLE COILED COIL: THE CRYSTAL STRUCTUREOF AN N-TERMINAL SEGMENT OF THE SCALLOP MYOSIN ROD CRYSTAL STRUCTURE OF GCN4-PIQ, A TRIMERIC COILED COIL WITH BURIED POLAR RESIDUES GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A TRIGONAL AUTOMATICSOLUTION ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL AUTOMATIC SOLUTION ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TRIGONAL FORM ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL FORM GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A COMPLEXED WITH BENZENE TMZIP: A CHIMERIC PEPTIDE MODEL OF THE N- TERMINUS OF ALPHA TROPOMYOSIN, NMR, 15 STRUCTURES CRYSTAL STRUCTURE OF B562RIL, A REDESIGNED FOUR HELIX BUNDLE STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES AN ANTI-PARALLEL FOUR HELIX BUNDLE MUTANT PLI-E20C GCN4 (BASIC REGION, LEUCINE ZIPPER) COMPLEX WITH AP-1 DEOXYRIBONUCLEIC ACID GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE DIMERIC STATE GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE TRIMERIC STATE GCN4-LEUCINE ZIPPER CORE MUTANT ASN16LYS IN THE DIMERIC STATE GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE DIMERIC STATE GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE TRIMERIC STATE LEUCINE ZIPPER MONOMER (NMR, 20 STRUCTURES) GCN4 BASIC DOMAIN, LEUCINE ZIPPER COMPLEXED WITH ATF/CREB SITE DEOXYRIBONUCLEIC ACID GCN4 LEUCINE ZIPPER AN ANTI-PARALLEL FOUR HELIX BUNDLE. ABA DOES NOT AFFECT TOPOLOGY OF PLI. AN ANTI-PARALLEL FOUR HELIX BUNDLE AN ANTI-PARALLEL FOUR HELIX BUNDLE AN ANTI-PARALLEL TO PARALLEL SWITCH. PDBE Y PDBE 2004-08-06 REL 4932 BAKER'S YEAST SACCHAROMYCES CEREVISIAE sample CHAIN A, B ENGINEERED MUTATION TYR 265 HIS, GLU 268 CYS THE N-TERMINUS OF THIS PEPTIDE IS CAPPED WITH ABA. DATA EXHIBITED SOME EPITAXIAL TWINNING, SLIGHTLY HIGH RFREE. n 1 1 A MET 2 n 2 MET 2 A LYS 3 n 3 LYS 3 A GLN 4 n 4 GLN 4 A ILE 5 n 5 ILE 5 A GLU 6 n 6 GLU 6 A ASP 7 n 7 ASP 7 A LYS 8 n 8 LYS 8 A LEU 9 n 9 LEU 9 A GLU 10 n 10 GLU 10 A GLU 11 n 11 GLU 11 A ILE 12 n 12 ILE 12 A LEU 13 n 13 LEU 13 A SER 14 n 14 SER 14 A LYS 15 n 15 LYS 15 A LEU 16 n 16 LEU 16 A HIS 17 n 17 HIS 17 A HIS 18 n 18 HIS 18 A ILE 19 n 19 ILE 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A GLU 22 n 22 GLU 22 A LEU 23 n 23 LEU 23 A ALA 24 n 24 ALA 24 A ARG 25 n 25 ARG 25 A ILE 26 n 26 ILE 26 A LYS 27 n 27 LYS 27 A LYS 28 n 28 LYS 28 A LEU 29 n 29 LEU 29 A LEU 30 n 30 LEU 30 A GLY 31 n 31 GLY 31 A GLU 32 n 32 GLU 32 A n 33 33 A n 1 1 B MET 2 n 2 MET 2 B LYS 3 n 3 LYS 3 B GLN 4 n 4 GLN 4 B ILE 5 n 5 ILE 5 B GLU 6 n 6 GLU 6 B ASP 7 n 7 ASP 7 B LYS 8 n 8 LYS 8 B LEU 9 n 9 LEU 9 B GLU 10 n 10 GLU 10 B GLU 11 n 11 GLU 11 B ILE 12 n 12 ILE 12 B LEU 13 n 13 LEU 13 B SER 14 n 14 SER 14 B LYS 15 n 15 LYS 15 B LEU 16 n 16 LEU 16 B HIS 17 n 17 HIS 17 B HIS 18 n 18 HIS 18 B ILE 19 n 19 ILE 19 B CYS 20 n 20 CYS 20 B ASN 21 n 21 ASN 21 B GLU 22 n 22 GLU 22 B LEU 23 n 23 LEU 23 B ALA 24 n 24 ALA 24 B ARG 25 n 25 ARG 25 B ILE 26 n 26 ILE 26 B LYS 27 n 27 LYS 27 B LYS 28 n 28 LYS 28 B LEU 29 n 29 LEU 29 B LEU 30 n 30 LEU 30 B GLY 31 n 31 GLY 31 B GLU 32 n 32 GLU 32 B n 33 33 B author_and_software_defined_assembly PQS 4 tetrameric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 2_765 -x+2,-y+1,z crystal symmetry operation 70.4760000000 35.2380000000 0.0000000000 1 A CD LYS 3 A CD LYS 3 1 Y 1 A CE LYS 3 A CE LYS 3 1 Y 1 A NZ LYS 3 A NZ LYS 3 1 Y 1 A CB GLN 4 A CB GLN 4 1 Y 1 A CG GLN 4 A CG GLN 4 1 Y 1 A CD GLN 4 A CD GLN 4 1 Y 1 A OE1 GLN 4 A OE1 GLN 4 1 Y 1 A NE2 GLN 4 A NE2 GLN 4 1 Y 1 A CG ASP 7 A CG ASP 7 1 Y 1 A OD1 ASP 7 A OD1 ASP 7 1 Y 1 A OD2 ASP 7 A OD2 ASP 7 1 Y 1 A CE LYS 8 A CE LYS 8 1 Y 1 A NZ LYS 8 A NZ LYS 8 1 Y 1 A CD GLU 10 A CD GLU 10 1 Y 1 A OE1 GLU 10 A OE1 GLU 10 1 Y 1 A OE2 GLU 10 A OE2 GLU 10 1 Y 1 A CD GLU 11 A CD GLU 11 1 Y 1 A OE1 GLU 11 A OE1 GLU 11 1 Y 1 A OE2 GLU 11 A OE2 GLU 11 1 Y 1 A CG HIS 18 A CG HIS 18 1 Y 1 A ND1 HIS 18 A ND1 HIS 18 1 Y 1 A CD2 HIS 18 A CD2 HIS 18 1 Y 1 A CE1 HIS 18 A CE1 HIS 18 1 Y 1 A NE2 HIS 18 A NE2 HIS 18 1 Y 1 A CD LYS 28 A CD LYS 28 1 Y 1 A CE LYS 28 A CE LYS 28 1 Y 1 A NZ LYS 28 A NZ LYS 28 1 Y 1 B CG LYS 3 B CG LYS 3 1 Y 1 B CD LYS 3 B CD LYS 3 1 Y 1 B CE LYS 3 B CE LYS 3 1 Y 1 B NZ LYS 3 B NZ LYS 3 1 Y 1 B CG GLN 4 B CG GLN 4 1 Y 1 B CD GLN 4 B CD GLN 4 1 Y 1 B OE1 GLN 4 B OE1 GLN 4 1 Y 1 B NE2 GLN 4 B NE2 GLN 4 1 Y 1 B CD GLU 6 B CD GLU 6 1 Y 1 B OE1 GLU 6 B OE1 GLU 6 1 Y 1 B OE2 GLU 6 B OE2 GLU 6 1 Y 1 B CE LYS 8 B CE LYS 8 1 Y 1 B NZ LYS 8 B NZ LYS 8 1 Y 1 B CD GLU 10 B CD GLU 10 1 Y 1 B OE1 GLU 10 B OE1 GLU 10 1 Y 1 B OE2 GLU 10 B OE2 GLU 10 1 Y 1 B CD GLU 11 B CD GLU 11 1 Y 1 B OE1 GLU 11 B OE1 GLU 11 1 Y 1 B OE2 GLU 11 B OE2 GLU 11 1 Y 1 B CE LYS 15 B CE LYS 15 1 Y 1 B NZ LYS 15 B NZ LYS 15 1 Y 1 B CD ARG 25 B CD ARG 25 1 Y 1 B NE ARG 25 B NE ARG 25 1 Y 1 B CZ ARG 25 B CZ ARG 25 1 Y 1 B NH1 ARG 25 B NH1 ARG 25 1 Y 1 B NH2 ARG 25 B NH2 ARG 25 1 Y 1 B CD LYS 28 B CD LYS 28 1 Y 1 B CE LYS 28 B CE LYS 28 1 Y 1 B NZ LYS 28 B NZ LYS 28 1 Y 1 B CG GLU 32 B CG GLU 32 1 Y 1 B CD GLU 32 B CD GLU 32 1 Y 1 B OE1 GLU 32 B OE1 GLU 32 1 Y 1 B OE2 GLU 32 B OE2 GLU 32 1 Y 1 A ARG 1 A ARG 1 1 Y 1 A ARG 33 A ARG 33 1 Y 1 B ARG 1 B ARG 1 1 Y 1 B ARG 33 B ARG 33 1 Y 1 16.87 2.70 111.00 127.87 A A A N CA C MET MET MET 2 2 2 N 1 13.03 1.80 110.60 123.63 A A A N CA CB HIS HIS HIS 18 18 18 N 1 -3.85 0.50 120.30 116.45 A A A NE CZ NH2 ARG ARG ARG 25 25 25 N 1 -22.44 2.30 111.70 89.26 A A A CD CE NZ LYS LYS LYS 27 27 27 N 1 -14.41 2.30 115.30 100.89 A A A CA CB CG LEU LEU LEU 30 30 30 N 1 11.60 0.90 118.30 129.90 B B B CB CG OD1 ASP ASP ASP 7 7 7 N 1 -6.39 0.90 118.30 111.91 B B B CB CG OD2 ASP ASP ASP 7 7 7 N 1 -9.74 1.60 122.70 112.96 B B B O C N GLU GLU GLU 10 10 11 Y 1 -10.42 1.20 123.30 112.88 B B B OE1 CD OE2 GLU GLU GLU 22 22 22 N 1 A A CA CB LEU LEU 16 16 -0.150 0.023 1.533 1.383 N 1 A A C O HIS HIS 17 17 -0.117 0.019 1.229 1.112 N 1 A A CD OE1 GLU GLU 22 22 0.141 0.011 1.252 1.393 N 1 B B C O CYS CYS 20 20 0.118 0.019 1.229 1.347 N 1 B B CB CG ASN ASN 21 21 0.162 0.023 1.506 1.668 N 1 B B C O GLY GLY 31 31 0.099 0.016 1.232 1.331 N 1 A LEU 30 -35.23 -30.26 0.914 0.873 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. N TERMINUS IS CAPPED WITH ABA. 0.344 0.280 0.282 2.50 35.41 116 2517 4.400 100.0 RANDOM 1 THROUGHOUT 2.000 MOLECULAR REPLACEMENT 0.563 0.369 0.80 0.80 1.40 MAXIMUM LIKELIHOOD BABINET MODEL WITH MASK 2.50 35.41 0 450 0 0 450 0.3040 0.3000 2.57 8 177 20 2.200 35.410 1W5H 3786 2.000 0.05000 1 17.2000 7.060 100.0 0.36000 2.20 2.28 4.700 1 7.11 100.0 refinement REFMAC 5.1.24 data reduction CrystalClear (MSC/RIGAKU) data scaling CrystalClear (MSC/RIGAKU) phasing MOLREP GENERAL CONTROL PROTEIN GCN4 An anti-parallel four helix bundle. 1 N N 1 N N A MET 2 A MET 2 HELX_P A GLU 32 A GLU 32 1 1 31 B MET 2 B MET 2 HELX_P B GLY 31 B GLY 31 1 2 30 FOUR HELIX BUNDLE FOUR HELIX BUNDLE, ANTIPARALLEL FOUR HELIX BUNDLE GCN4_YEAST UNP 1 P03069 249 281 1W5H 1 33 P03069 A 1 1 33 249 281 1W5H 1 33 P03069 B 1 1 33 1 LEU conflict ILE 5 1W5H A P03069 UNP 253 5 1 VAL conflict LEU 9 1W5H A P03069 UNP 257 9 1 LEU conflict ILE 12 1W5H A P03069 UNP 260 12 1 ASN conflict LEU 16 1W5H A P03069 UNP 264 16 1 TYR engineered mutation HIS 17 1W5H A P03069 UNP 265 17 1 LEU conflict ILE 19 1W5H A P03069 UNP 267 19 1 GLU engineered mutation CYS 20 1W5H A P03069 UNP 268 20 1 VAL conflict LEU 23 1W5H A P03069 UNP 271 23 1 LEU conflict ILE 26 1W5H A P03069 UNP 274 26 1 VAL conflict LEU 30 1W5H A P03069 UNP 278 30 2 LEU conflict ILE 5 1W5H B P03069 UNP 253 5 2 VAL conflict LEU 9 1W5H B P03069 UNP 257 9 2 LEU conflict ILE 12 1W5H B P03069 UNP 260 12 2 ASN conflict LEU 16 1W5H B P03069 UNP 264 16 2 TYR engineered mutation HIS 17 1W5H B P03069 UNP 265 17 2 LEU conflict ILE 19 1W5H B P03069 UNP 267 19 2 GLU engineered mutation CYS 20 1W5H B P03069 UNP 268 20 2 VAL conflict LEU 23 1W5H B P03069 UNP 271 23 2 LEU conflict ILE 26 1W5H B P03069 UNP 274 26 2 VAL conflict LEU 30 1W5H B P03069 UNP 278 30 94 P 42 21 2